dr. louis weiner discusses the t-dm1 emilia trial for her2-positive breast cancer
Published 11 years ago • 237 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
0:57
dr. louis weiner on the t-dm1 mechanism of action in her2-positive breast cancer
-
1:38
dr. debu tripathy discusses the updated emilia trial results for t-dm1
-
4:33
upfront t-dm1 in her2-positive breast cancer
-
3:58
frontline t-dm1 in her2-positive metastatic breast cancer
-
2:00
dr. esteva discusses t-dm1 in her2-positive breast cancer
-
1:07
dr. tripathy discusses impact of t-dm1 in her2 breast cancer
-
0:56
dr. jhaveri discusses the utility of t-dm1 in the neoadjuvant setting
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
2:00
her2 metastatic breast cancer: standard of care therapies
-
4:04
neoadjuvant t-dm1 in her2 early breast cancer
-
1:52
dr. mark pegram discusses earlier treatment with t-dm1
-
1:06
dr. edith perez on the antibody-drug conjugate t-dm1
-
1:13
dr. julie gralow discusses t-dm1-induced thrombocytopenia
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
8:40
first-line treatment of her2-positive metastatic breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
2:05
dr. geyer discusses challenges in her2-positive metastatic breast cancer management
-
8:12
her2 testing in metastatic breast cancer